ARCHIVES

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Study Section Members Likelier to Be Funded

August 1, 1986

M.D. Anderson, Madrid In Joint Program

September 2, 1988

President Obama Signs FDA User Fee Act Into Law

July 13, 2012

Men Over Age 75 Shouldn’t Be Screened For Prostate Cancer, Task Force Says

August 29, 2008

Legislation Would Create Medicare Service For Comprehensive Cancer Care planning.

May 26, 2006

DRG Reimbursement Schedules Estimated for High, Low Areas; City Of Hope Added to Exemptions, Other Without Much Hope

November 18, 1983